Provided by Tiger Trade Technology Pte. Ltd.

TJ DaRenTang USD

3.290
+0.0100.30%
Volume:184.20K
Turnover:607.51K
Market Cap:2.53B
PE:5.04
High:3.330
Open:3.310
Low:3.280
Close:3.280
52wk High:3.750
52wk Low:1.653
Shares:770.00M
Float Shares:421.34M
Volume Ratio:1.39
T/O Rate:0.04%
Dividend:0.19
Dividend Rate:5.63%
EPS(TTM):0.653
EPS(LYR):2.900
ROE:46.11%
ROA:4.92%
PB:1.94
PE(LYR):1.13

Loading ...

Tianjin Pharmaceutical Da Ren Tang Group Provides February Update on Subsidiary Bankruptcy

SGX Filings
·
Feb 27

SGX Weekly Review | STI up 0.6%; TJ DaRenTang, POP MART HK SDR Soar 12%; SingaporeLandGrp Rises 10%; SMIC HK SDR, Tencent HK SDR Drop 9%

TigerNews SG
·
Feb 07

Stock Track | TJ DaRenTang USD Soars 3.44% as Controlling Shareholder Increases Stake

Stock Track
·
Feb 06

Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%

MT Newswires
·
Feb 06

Tianjin Pharmaceutical Da Ren Tang’s parent adds to Singapore-listed stake, plans further buys

SGX Filings
·
Feb 05

Tianjin Pharmaceutical Da Ren Tang Group Issues January Update on Subsidiary Bankruptcy Proceedings

SGX Filings
·
Jan 30

Tianjin Pharmaceutical Da Ren Tang Group issues December update on subsidiary’s bankruptcy liquidation

SGX Filings
·
Dec 31, 2025

Tianjin Pharmaceutical Da Ren Tang provides monthly update on subsidiary’s bankruptcy process

SGX Filings
·
Nov 28, 2025

Tianjin Pharmaceutical Da Ren Tang receives Chinese approval for loxoprofen pain patch

SGX Filings
·
Nov 25, 2025

Tianjin Pharmaceutical Da Ren Tang's Unit Granted Registration Certificate by Chinese Authority

MT Newswires
·
Nov 25, 2025

Tianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on 9-Month 2025 Results

SGX Filings
·
Nov 24, 2025

Tianjin Pharmaceutical Da Ren Tang posts RMB224.6 m third-quarter profit, lifts nine-month earnings to RMB2.15 bn on disposal gain

SGX Filings
·
Oct 30, 2025

Tianjin Pharmaceutical Da Ren Tang Plans Governance Overhaul, Seeks Shareholder Nod

SGX Filings
·
Oct 30, 2025

Tianjin Pharmaceutical Da Ren Tang's Q3 Attributable Jumps 54% in Q3

MT Newswires
·
Oct 30, 2025

Tianjin Pharmaceutical Da Ren Tang issues September update on subsidiary bankruptcy proceedings

SGX Filings
·
Sep 30, 2025